1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Osteoarthritis Pain Market Size Growth Rate by Type (2020-2025)
1.3.2 Oral
1.3.3 Non-Oral
1.4 Market Segment by Application
1.4.1 Global Osteoarthritis Pain Market Share by Application (2020-2025)
1.4.2 Hospital
1.4.3 Pharmacy
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Osteoarthritis Pain Production Value 2015-2025
2.1.2 Global Osteoarthritis Pain Production 2015-2025
2.1.3 Global Osteoarthritis Pain Capacity 2015-2025
2.1.4 Global Osteoarthritis Pain Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2020-2025
2.2.1 Global Osteoarthritis Pain Market Size CAGR of Key Regions
2.2.2 Global Osteoarthritis Pain Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Osteoarthritis Pain Capacity by Manufacturers
3.1.2 Global Osteoarthritis Pain Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Osteoarthritis Pain Revenue by Manufacturers (2015-2019)
3.2.2 Osteoarthritis Pain Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)
3.3 Osteoarthritis Pain Price by Manufacturers
3.4 Key Manufacturers Osteoarthritis Pain Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Osteoarthritis Pain Market
3.6 Key Manufacturers Osteoarthritis Pain Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Oral Production and Production Value (2015-2019)
4.1.2 Non-Oral Production and Production Value (2015-2019)
4.2 Global Osteoarthritis Pain Production Market Share by Type
4.3 Global Osteoarthritis Pain Production Value Market Share by Type
4.4 Osteoarthritis Pain Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Osteoarthritis Pain Consumption by Application
6 Production by Regions
6.1 Global Osteoarthritis Pain Production (History Data) by Regions 2015-2019
6.2 Global Osteoarthritis Pain Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Osteoarthritis Pain Production Growth Rate 2015-2019
6.3.2 United States Osteoarthritis Pain Production Value Growth Rate 2015-2019
6.3.3 Key Players in United States
6.3.4 United States Osteoarthritis Pain Import & Export
6.4 European Union
6.4.1 European Union Osteoarthritis Pain Production Growth Rate 2015-2019
6.4.2 European Union Osteoarthritis Pain Production Value Growth Rate 2015-2019
6.4.3 Key Players in European Union
6.4.4 European Union Osteoarthritis Pain Import & Export
6.5 China
6.5.1 China Osteoarthritis Pain Production Growth Rate 2015-2019
6.5.2 China Osteoarthritis Pain Production Value Growth Rate 2015-2019
6.5.3 Key Players in China
6.5.4 China Osteoarthritis Pain Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Osteoarthritis Pain Consumption by Regions
7.1 Global Osteoarthritis Pain Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Osteoarthritis Pain Consumption by Type
7.2.2 United States Osteoarthritis Pain Consumption by Application
7.3 European Union
7.3.1 European Union Osteoarthritis Pain Consumption by Type
7.3.2 European Union Osteoarthritis Pain Consumption by Application
7.4 China
7.4.1 China Osteoarthritis Pain Consumption by Type
7.4.2 China Osteoarthritis Pain Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Osteoarthritis Pain Consumption by Type
7.5.2 Rest of World Osteoarthritis Pain Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Abbott Laboratories Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Osteoarthritis Pain
8.1.4 Osteoarthritis Pain Product Introduction
8.1.5 Abbott Laboratories Recent Development
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Osteoarthritis Pain
8.2.4 Osteoarthritis Pain Product Introduction
8.2.5 Johnson & Johnson Recent Development
8.3 Novartis International
8.3.1 Novartis International Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Osteoarthritis Pain
8.3.4 Osteoarthritis Pain Product Introduction
8.3.5 Novartis International Recent Development
8.4 Pfizer
8.4.1 Pfizer Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Osteoarthritis Pain
8.4.4 Osteoarthritis Pain Product Introduction
8.4.5 Pfizer Recent Development
8.5 AbbVie
8.5.1 AbbVie Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Osteoarthritis Pain
8.5.4 Osteoarthritis Pain Product Introduction
8.5.5 AbbVie Recent Development
8.6 Abiogen Pharma
8.6.1 Abiogen Pharma Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Osteoarthritis Pain
8.6.4 Osteoarthritis Pain Product Introduction
8.6.5 Abiogen Pharma Recent Development
8.7 Afferent Pharmaceuticals
8.7.1 Afferent Pharmaceuticals Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Osteoarthritis Pain
8.7.4 Osteoarthritis Pain Product Introduction
8.7.5 Afferent Pharmaceuticals Recent Development
8.8 Astellas Pharma
8.8.1 Astellas Pharma Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Osteoarthritis Pain
8.8.4 Osteoarthritis Pain Product Introduction
8.8.5 Astellas Pharma Recent Development
8.9 BioDelivery Sciences International
8.9.1 BioDelivery Sciences International Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Osteoarthritis Pain
8.9.4 Osteoarthritis Pain Product Introduction
8.9.5 BioDelivery Sciences International Recent Development
8.10 Crystal Genomics
8.10.1 Crystal Genomics Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Osteoarthritis Pain
8.10.4 Osteoarthritis Pain Product Introduction
8.10.5 Crystal Genomics Recent Development
8.11 Cytori Therapeutics
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Osteoarthritis Pain Capacity, Production Forecast 2020-2025
9.1.2 Global Osteoarthritis Pain Production Value Forecast 2020-2025
9.2 Market Forecast by Regions
9.2.1 Global Osteoarthritis Pain Production and Value Forecast by Regions 2020-2025
9.2.2 Global Osteoarthritis Pain Consumption Forecast by Regions 2020-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Osteoarthritis Pain Production Forecast by Type
9.7.2 Global Osteoarthritis Pain Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Osteoarthritis Pain Sales Channels
10.2.2 Osteoarthritis Pain Distributors
10.3 Osteoarthritis Pain Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter\'s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
